Sofinnova Crossover I SLP

Insider profile

Sofinnova Crossover I SLP's trades of Abivax SA's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Proposed sale
Price
124.80
Quantity 81,565
Value US$3,023,024
Transaction date
Proposed sale
Price
154.78
Quantity 4,888
Value US$2,346,199
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2026-01-08 2026-01-08 PrS Proposed sale
81,565
124.80
US$3,023,024
81,565 124.80 US$3,023,024
2025-10-28 2025-10-28 PrS Proposed sale
4,888
154.78
US$2,346,199
4,888 154.78 US$2,346,199